Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q17092352> ?p ?o }
Showing triples 1 to 38 of
38
with 100 triples per page.
- Q17092352 subject Q11705706.
- Q17092352 subject Q6448504.
- Q17092352 subject Q7013781.
- Q17092352 subject Q7056690.
- Q17092352 abstract "Patient recruitment includes a variety of services—typically performed by a Patient Recruitment Service Provider—to increase enrollment into clinical trials. Presently, the patient recruitment industry is claimed to total $5.9 billion per year.Patient enrollment is the most time-consuming aspect of the clinical trial process. The leading cause of missed clinical trial deadlines is patient recruitment, taking up to 30 percent of the clinical timeline. Improving patient recruitment rates offers pharmaceutical and medical device companies one of the biggest opportunities to accelerate the pace of clinical trials – making it possible to reduce time to market. As the number of patients needed for clinical trials rises – as safety and regulatory issues drive trends toward larger and longer trials – the demand for patient recruitment services grows.Clinical trials are conducted to collect data regarding the safety and efficacy of new drug and device development. They are conducted in a series of phases, each designed to address a separate purpose: Phase I: Researchers test a new drug or treatment in a small group of people (20-80) for the first time to evaluate its safety, determine a safe dosage range, and identify side effects. Phase II: The study drug or treatment is given to a larger group of people (100-300) to see if it is effective and to further evaluate its safety. Phase III: The study drug or treatment is given to large groups of people (1,000-3,000) to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely. Phase IV: Post marketing studies delineate additional information including the drug's risks, benefits, and optimal use.Pharmaceutical companies submit trial data to the U.S. Food and Drug Administration (FDA) as part of a New Drug Application, the application for FDA approval to market a drug in the U.S.Patient recruitment service providers educate the public about the value of clinical trial participation and the measures in place to protect study participants. The 2001 “Will & Why Survey” of more than 5,000 people in the U.S. showed that 81 percent of the population was not aware of safeguards such as the Declaration of Helsinki, The Belmont Report, Institutional Review Boards, and the informed consent process. However, after learning about these protective measures, nearly 40 percent of respondents reported they would be more likely to participate in a clinical trials.".
- Q17092352 wikiPageWikiLink Q11081.
- Q17092352 wikiPageWikiLink Q1126687.
- Q17092352 wikiPageWikiLink Q11705706.
- Q17092352 wikiPageWikiLink Q12140.
- Q17092352 wikiPageWikiLink Q1368197.
- Q17092352 wikiPageWikiLink Q1851835.
- Q17092352 wikiPageWikiLink Q202833.
- Q17092352 wikiPageWikiLink Q204711.
- Q17092352 wikiPageWikiLink Q2329814.
- Q17092352 wikiPageWikiLink Q30.
- Q17092352 wikiPageWikiLink Q30612.
- Q17092352 wikiPageWikiLink Q3117735.
- Q17092352 wikiPageWikiLink Q35127.
- Q17092352 wikiPageWikiLink Q362104.
- Q17092352 wikiPageWikiLink Q445235.
- Q17092352 wikiPageWikiLink Q553079.
- Q17092352 wikiPageWikiLink Q5690948.
- Q17092352 wikiPageWikiLink Q626741.
- Q17092352 wikiPageWikiLink Q6448504.
- Q17092352 wikiPageWikiLink Q6554101.
- Q17092352 wikiPageWikiLink Q6900510.
- Q17092352 wikiPageWikiLink Q7013781.
- Q17092352 wikiPageWikiLink Q7056690.
- Q17092352 wikiPageWikiLink Q7168241.
- Q17092352 wikiPageWikiLink Q755009.
- Q17092352 wikiPageWikiLink Q760102.
- Q17092352 wikiPageWikiLink Q764527.
- Q17092352 wikiPageWikiLink Q777473.
- Q17092352 wikiPageWikiLink Q866.
- Q17092352 wikiPageWikiLink Q918.
- Q17092352 wikiPageWikiLink Q953806.
- Q17092352 comment "Patient recruitment includes a variety of services—typically performed by a Patient Recruitment Service Provider—to increase enrollment into clinical trials. Presently, the patient recruitment industry is claimed to total $5.9 billion per year.Patient enrollment is the most time-consuming aspect of the clinical trial process. The leading cause of missed clinical trial deadlines is patient recruitment, taking up to 30 percent of the clinical timeline.".
- Q17092352 label "Patient recruitment".